UNSPSC 51433100: Antihypertensive peptides

Antihypertensive drugs made from members of the class of compounds composed of amino acids joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. oligopeptides are composed of approximately 2-12 amino acids

UNSPSC 51433100 Antihypertensive peptides is a Class code that, based on recent state and local activity, encompasses emergency and critical-care pharmaceuticals supplied to public health and safety agencies. State and local governments buying under this code procure specific medication line items—including vasopressor agents, cardiac medications, and antiarrhythmic compounds—for use by fire rescue departments, emergency medical services, and state health agencies. The issuing bodies include municipal fire departments, state health and human services commissions, and multistate cooperative purchasing alliances coordinating acquisitions across multiple jurisdictions. Vendors supply products through authorized pharmaceutical wholesalers, must maintain strict expiration and shelf-life standards (typically nine months to one year from delivery), comply with FDA requirements and Good Manufacturing Practices, and provide comprehensive Safety Data Sheets and accessibility documentation as required by OSHA and federal accessibility standards.

Recent activity spans Florida, Texas, and Minnesota, with multistate cooperative vehicles driving significant volume. The City of Tampa's Purchasing Department posted an IFB (Solicitation 26P00188) on April 24, 2026, seeking Advanced Life Support Medications including Labetalol HCI, Epinephrine, Adenosine, and Diltiazem vials for Tampa Fire Rescue, with a response deadline of April 8, 2026 and an estimated contract value of $40,000—a one-year contract with two optional renewals and a Small Local Business Enterprise sheltered-market designation offering a 5 percent bid discount. The Texas Health and Human Services Commission issued an RFI (HHS0017013) posted April 3, 2026 to assess vendor capability for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The Minnesota Multistate Cooperative Purchasing Alliance posted an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, with an effective date of July 1, 2026 and a two-year contract term for multiple state and local government facilities including Oregon, requiring vendors to work through AmerisourceBergen, Cardinal Health, and Morris & Dickson Co. as authorized wholesalers.